Regulating Healthcare at the Speed of Life
How can regulators and healthcare companies work together to drive innovation? Hear from a panel of experts.
A New Lens for Advancing American Kidney Health
Chronic kidney disease is a silent killer that costs Medicare over $120 billion dollars annually. The 80 million Americans at risk of developing the disease are still mostly unaware of the threat—and are at a heightened risk from COVID-19 as well. Allowing them to test from the safety of home with their smartphone can help […]
The Future of Healthcare Beyond COVID-19: These Disruptors Are Paving the Way
Last month, CNBC selected Healthy.io and seven other healthcare companies for its annual Disruptor 50 list of “private companies whose breakthroughs are influencing business and market competition at an accelerated pace.” The non-healthcare companies on the list include such luminaries as Coursera, Airbnb and Lemonade. Disruption is what happens when a lean and nimble tech […]
Chronic Conditions Will Outlast the Pandemic: How Can We Manage Both?
These are trying times for anyone in need of care, but they are particularly challenging for people with chronic conditions, such as diabetes, hypertension, or heart disease. A variety of complementary solutions—ranging from remote care and behavioral science to awareness campaigns and regulatory action—is needed to make sure they receive the care they need during […]
Managing Chronic Wounds During the COVID-19 Pandemic
The COVID-19 pandemic is front and centre of all current healthcare priorities – and rightly so. Yet, we must not, nor should not, overlook the need for other forms of healthcare provision – which have by no means abated. Take the management of wound care. It is estimated that 2.2 million people in the UK […]
